Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJG9B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,082
Award facts
- Contract value 100% obligated
- $15,081.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,081.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 300 mg/2 mL Dupixent (dupilumab) pens on January 8, 2026, with an ultimate completion date of January 9, 2026. Dupixent is a monoclonal antibody used to treat moderate-to-severe eczema, asthma, and other allergic conditions. This non-set-aside, competitively awarded contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal government healthcare systems including military treatment facilities and veterans' healthcare programs.
This delivery order is issued under AmerisourceBergen's parent company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 31, 2031. This comprehensive IDC serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. AmerisourceBergen's extensive contract portfolio with the Defense Logistics Agency demonstrates its established capability to fulfill federal pharmaceutical procurement requirements through open competition.
Quick answers
Who was awarded contract SPE2DR26FJG9B?
SPE2DR26FJG9B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FJG9B worth?
The government has obligated $15,082 on SPE2DR26FJG9B.
Is contract SPE2DR26FJG9B an order under another contract?
Yes. SPE2DR26FJG9B is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJG9B competed?
The extent of competition for SPE2DR26FJG9B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award